VolitionRx Limited
VNRX · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | 54.2% | 65.1% | 28.6% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $2 | $3 | $3 | $3 |
| G&A Expenses | $3 | $4 | $3 | $3 |
| SG&A Expenses | $3 | $4 | $3 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $6 | $7 | $6 | $6 |
| Operating Income | -$5 | -$6 | -$6 | -$6 |
| % Margin | -813.2% | -1,548.6% | -2,241.1% | -3,016.5% |
| Other Income/Exp. Net | -$0 | -$0 | $0 | -$0 |
| Pre-Tax Income | -$5 | -$6 | -$5 | -$6 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5 | -$6 | -$5 | -$6 |
| % Margin | -857.4% | -1,545.2% | -2,201.3% | -3,022.8% |
| EPS | -0.05 | -0.061 | -0.056 | -0.066 |
| % Growth | 18.3% | -8.9% | 14.8% | – |
| EPS Diluted | -0.05 | -0.061 | -0.056 | -0.066 |
| Weighted Avg Shares Out | 108 | 103 | 97 | 87 |
| Weighted Avg Shares Out Dil | 108 | 103 | 97 | 87 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$4 | -$6 | -$5 | -$5 |
| % Margin | -673.9% | -1,363.9% | -2,058.4% | -2,824.1% |